Argus analyst Kevin Heal lowered the firm’s price target on Huntington Bancshares (HBAN) to $17 from $19 but keeps a Buy rating on the shares after its Q1 earnings beat. Regional bank shares have recently faced pressure due to potential policy decisions from the Administration, though on its earnings call, Huntington management noted that it saw growth in loans and deposits along with higher fee income, the analyst tells investors in a research note. The stock also carries an attractive dividend with a slightly above-peer-average yield of about 4.4%, Argus adds.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBAN:
- Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
- Huntington Bancshares price target lowered to $17 from $21 at Truist
- Huntington Bancshares price target lowered to $18 from $20 at RBC Capital
- Huntington Bancshares price target lowered to $18 from $20 at Raymond James
- Huntington Bancshares price target raised to $16 from $15 at Morgan Stanley